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      Dear  Sir: 
  In response to Hossain and others  1   paper on hospital based 
surveillance confirming the presence of Japanese Encephalitis 
(JE) in Bangladesh. We comment on the small proportion of 
confirmed cases of JE and the need to clarify sample timing 
of sample relative to onset of illness to confirm absence of JE 
virus in the enzyme-linked immunosorbent assay (ELISA) 
negative cases. 
  Hossain and others’  1   paper on hospital-based surveillance 
for JE in Bangladesh provides important data on the spread 
of this devastating disease.  1   This paper is important, because it 
shows further evidence of JE in Bangladesh, previously only 
reported during an outbreak in 1977.  2  
  They systematically assessed an impressive 2,609 patients 
over four study sites, with 492 meeting their criteria for 
screening for JE virus (JEV). Of the cases of acute encepha-
litis (AES), their results confirm that 4% had JEV. It is also 
important to consider the patients with negative ELISA 
results for JEV; 472 (96%) of the patients had an unknown 
cause of their AES. ELISA testing is the method of choice for 
JEV, because viraemia is too transient for molecular meth-
ods, such as polymerase chain reaction, to be useful. There are 
data that show that IgM responses to JEV take between 7 and 
10 days to develop.  3,  4   However, there are also data to suggest 
that an early low cerebrospinal fluid (CSF) immunoglobulin 
(Ig)M response may be suggestive of a poor outcome  5  ; thus, if 
the CSF IgM rise is only transient, it may be missed by single 
sampling. Accurate diagnostics in the field are notoriously dif-
ficult, but it is crucial that this problem is highlighted and that 
timing of samples is clearly described so as not to engender 
complacency about the real prevalence and incidence of JE in 
cases of AES. 
  The current World Health Organization (WHO) JE sur-
veillance standards recommend a sample at ≥ 10 day of illness 
to confirm or exclude JEV.  6   Patients with early JEV ELISA 
negative samples should, thus, not be classified as JE nega-
tive but instead, as having JEV unknown status. Although it 
can be difficult to get the timing of the illness onset, it is pref-
erable, where possible, to distinguish between JEV negative 
and JEV unknown, so that the JEV unknown cases can be 
excluded from any calculations of the proportion of cases 
caused by JEV. These data are helpful in informing govern-
ment and funding bodies as to where to target JE vaccination 
programs. 
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